Nexalin Technology Inc. (NXL) is a Healthcare · Medical Devices company listed on NASDAQ. Price $4.97 (-2.53%), Market cap $0.01B, 52-week low–high $0.32 ~ $1.86.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Financial statements, price targets, institutional (13F) holdings and related news for Nexalin Technology Inc. are updated in real time on BlackAll Trade.
Nexalin Technology Inc. trades at $4.97 (-2.53%). Real-time quotes and charts are available on BlackAll Trade.
Nexalin Technology Inc. has a market cap of about $0.01B.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Genera